Unusual extramedullary relapses under imatinib mesylate treatment in chronic myeloid leukemia [1]

American Journal of Hematology

Volumn 79, Issue 1, 2005, Pages 79-80

  Beyazit, Yavuz ^a   Aksu, Salih ^a   Kekilli, Murat ^a   Haznedaroglu, Ibrahim C ^a   Kilickap, Sadettin ^a   Goker, Hakan ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTARABINE; HYDROXYUREA; IMATINIB;

ADULT; ADVANCED CANCER; CANCER STAGING; CASE REPORT; CHRONIC MYELOID LEUKEMIA; FEMALE; HUMAN; LETTER; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MYELOBLAST; PRIORITY JOURNAL; SYSTEMIC THERAPY; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC AGENTS; BLOOD CELL COUNT; FEMALE; HUMANS; LEUKEMIA, MYELOID, CHRONIC; LYMPHATIC DISEASES; MIDDLE AGED; PIPERAZINES; PLEURAL EFFUSION; PYRIMIDINES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 18044371428     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20274     Document Type: Letter

References (4)

1. Higashi T, Tsukada J, Kato C, et al. Imatinib mesylate-sensitive blast crisis immediately after discontinuation of imatinib mesylate therapy in chronic myelogenous leukemia: report of two cases. Am J Hematol 2004;76:275-278.
2. Bujassoum S, Rifkind J, Lipton JH. Isolated central nervous system relapse in lymphoid blast crisis chronic myeloid leukemia and acute lymphoblastic leukemia in patients on imatinib therapy. Leuk Lymphoma 2004;45:401-403.
3. Liso V, Specchia G, Pogliani EM. et al. Extramedullary involvement in patients with acute promyelocytic leukemia: a report of seven cases. Cancer 1998;83:1522-1528.
4. Taraboletti G, Borsotti P, Chirivi RG, et al. Effect of all-trans-retinoic acid (ATRA) on the adhesive and motility properties of acute promyelocytic leukemia cells. Int J Cancer 1997;70:72-77.